Rhythm Biosciences Limited (ASX:RHY)
0.0610
-0.0030 (-4.69%)
May 16, 2025, 10:06 AM AEST
Rhythm Biosciences Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2017 - 2019 |
Cash & Equivalents | 4.37 | 0.71 | 4.12 | 7.55 | 2.23 | 1.8 | Upgrade
|
Short-Term Investments | 0.09 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
Cash & Short-Term Investments | 4.45 | 0.75 | 4.17 | 7.6 | 2.27 | 1.84 | Upgrade
|
Cash Growth | 252.70% | -81.90% | -45.11% | 234.10% | 23.36% | -61.39% | Upgrade
|
Other Receivables | 0.08 | 0.04 | 0.07 | 0.08 | 0.16 | 0.14 | Upgrade
|
Receivables | 0.08 | 0.04 | 0.07 | 0.08 | 0.16 | 0.14 | Upgrade
|
Inventory | 0.09 | - | 2.77 | - | - | - | Upgrade
|
Prepaid Expenses | 0.21 | 0.09 | 0.12 | 0.09 | 0.06 | 0.02 | Upgrade
|
Total Current Assets | 4.83 | 0.89 | 7.12 | 7.77 | 2.49 | 2.01 | Upgrade
|
Property, Plant & Equipment | 0.24 | 0.28 | 0.19 | 0.24 | 0.11 | 0.14 | Upgrade
|
Other Intangible Assets | 0.34 | 0.35 | 0.39 | 0.43 | 0.46 | 0.5 | Upgrade
|
Total Assets | 5.93 | 1.52 | 7.7 | 8.44 | 3.07 | 2.65 | Upgrade
|
Accounts Payable | 0.75 | 0.21 | 1.33 | 0.28 | 0.6 | 0.56 | Upgrade
|
Accrued Expenses | - | 0.27 | 0.35 | 0.57 | 0.74 | 0.19 | Upgrade
|
Current Portion of Leases | 0.11 | 0.08 | 0.08 | 0.09 | - | 0.04 | Upgrade
|
Total Current Liabilities | 0.99 | 0.56 | 1.77 | 0.93 | 1.34 | 0.79 | Upgrade
|
Long-Term Leases | 0.05 | 0.09 | - | 0.08 | - | - | Upgrade
|
Other Long-Term Liabilities | 0.01 | 0 | 0.06 | 0.05 | 0.02 | 0.01 | Upgrade
|
Total Liabilities | 1.05 | 0.65 | 1.82 | 1.07 | 1.36 | 0.8 | Upgrade
|
Common Stock | 37.73 | 34.45 | 31.55 | 27.83 | 15.98 | 10.04 | Upgrade
|
Retained Earnings | -38.08 | -38.67 | -31.82 | -23.6 | -14.81 | -8.39 | Upgrade
|
Comprehensive Income & Other | 5.23 | 5.09 | 6.14 | 3.14 | 0.53 | 0.19 | Upgrade
|
Shareholders' Equity | 4.88 | 0.87 | 5.87 | 7.37 | 1.71 | 1.84 | Upgrade
|
Total Liabilities & Equity | 5.93 | 1.52 | 7.7 | 8.44 | 3.07 | 2.65 | Upgrade
|
Total Debt | 0.16 | 0.16 | 0.08 | 0.17 | - | 0.04 | Upgrade
|
Net Cash (Debt) | 4.3 | 0.59 | 4.08 | 7.43 | 2.27 | 1.8 | Upgrade
|
Net Cash Growth | 250.96% | -85.54% | -44.99% | 226.62% | 26.26% | -62.28% | Upgrade
|
Net Cash Per Share | 0.02 | 0.00 | 0.02 | 0.04 | 0.01 | 0.02 | Upgrade
|
Filing Date Shares Outstanding | 283.6 | 248.6 | 220.92 | 214.18 | 202.25 | 115.86 | Upgrade
|
Total Common Shares Outstanding | 283.6 | 248.6 | 219.79 | 214.18 | 202.17 | 100.75 | Upgrade
|
Working Capital | 3.84 | 0.32 | 5.35 | 6.84 | 1.15 | 1.21 | Upgrade
|
Book Value Per Share | 0.02 | 0.00 | 0.03 | 0.03 | 0.01 | 0.02 | Upgrade
|
Tangible Book Value | 4.01 | 0.51 | 5.48 | 6.95 | 1.24 | 1.35 | Upgrade
|
Tangible Book Value Per Share | 0.01 | 0.00 | 0.02 | 0.03 | 0.01 | 0.01 | Upgrade
|
Machinery | - | 0.46 | 0.37 | 0.28 | 0.26 | 0.18 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.